17-1-20, Congrès [de Versailles] abbé Walter [Joseph] général Hirschauer, général Berdoulat [Pierre] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57691

17-1-20, Congrès de Versailles, M. Albert Thomas : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57686

17-1-20, Congrès de Versailles, général de Castelnau : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57682

17-1-20, Congrès de Versailles (salle des séances) : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57678

Vel d'Hiv, 17-12-19, départ du prix Lapize, Berbes [?], Girardengo, Van Neck : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57172

17-12-19, cross country à Antony (interclubs des White Harriers) Redinger, gagnant club Société Générale : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57170

Histoire du dix-neuvième siècle depuis les traités de Vienne. Tome 17 / G. G. Gervinus,... ; traduit de l'allemand par J.-F. Minssen,...

Collection : Collection d'historiens contemporains

ABD e-News September 17, 2004

Weekly newsletter for the State of Iowa Alcoholic Beverages Division

ABD e-News In Memoriam September 17, 2004

Weekly newsletter for the State of Iowa Alcoholic Beverages Division - In Memoriam

Report of Recommendations to the University of Northern Iowa on the Review of Selected General and Application Controls Over the Modern Executive Management Financial Information, June 2 to July 17, 2003

State University Audit Report

Lottery Action, April 4-17, 2005, Vol. 12, no. 7

Lottery Newsletter for retailers

Modern Vaccines/Adjuvants Formulation-Session 2 (Plenary II): May 15-17, 2013-Lausanne, Switzerland.

On the 15-17th May 2013, the Fourth International Conference on Modern Vaccines/Adjuvants Formulation was organized in Lausanne, Switzerland, and gathered stakeholders from academics and from the industry to discuss several challenges, advances and promises in the field of vaccine adjuvants. Plenary session 2 of the meeting was composed of four different presentations covering: (1) the recent set-up of an adjuvant technology transfer and training platform in Switzerland, (2) the proposition to revisit existing paradigms of modern vaccinology, (3) the properties of polyethyleneimine as potential new vaccine adjuvant, and (4) the progresses in the design of HIV vaccine candidates able to induce broadly neutralizing antibodies.